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Binding of Aromatic Amines to the Rat
Hepatic Ah Receptor In Vitro and In Vivo
and to the 8S and 4S Estrogen Receptor of
Rat Uterus and Rat Liver
by Peter Cikryt,* Thomas Kaiser,* and Martin Gottlicher*t
Studies on structurally related aromatic amines with different carcinogenic properties have shown that
2-acetylaminofluorene (2-AAF) and 2-acetylaminophenanthrene (AAP) inhibit the binding of 2,3,7,8-te-
trachlorodibenzo-p-dioxin to the Ah receptor in vitro. The apparent inhibitor constants (Ks) are 2.3 FM
for 2-AAF and 2.7 ,uM for AAP. In contrast, 4-acetylaminofluorene, an isomer of 2-AAF, and trans-4-
acetylaminostilbene do not bind to the rat hepatic cytosolic Ah receptor. Pretreating female Wistar rats
with 2-AAF or AAP leads to the induction of the P-450 isoenzymes that are under the control of the Ah
receptor. Ornithine decarboxylase activity is induced by all aromatic amines tested irrespective of their
Ah receptor affinity. The aromatic amines used as model compounds do not inhibit the binding of 17-r-
estradiol to the 8S and 4S estrogen receptor of rat uterus or rat liver in a competition assay analyzed
using sucrose density gradient centrifugation. On the other hand, the aromatic amines bind to varying
extents to another estrogen-binding protein ofrat liver whose function and identity is still unknown. Our
study demonstrates that structurally related aromatic amines in their unmetabolized form interact dif-
ferentially with acellulartargetprotein, theAhreceptor, in vitroaswell as in vivo. However, arelationship
between these effects and the postulated promoting properties of 2-AAF remains to be established.
Introduction
Aromatic amines are widely used in the production
of azo dyes, drugs, pesticides, and plastics. The carcin-
ogenic potential ofthese compounds was already estab-
lished at the beginning ofindustrial dye production (1).
The most important aromatic amines ofindustrial origin
that are responsible for human bladder cancer are 2-
naphthylamine, benzidine, and 4-aminobiphenyl. An-
other aromatic amine,: 2-acetylaminofluorene (2-AAF),
which was originally intended for use as an insecticide,
has gained great importance as a model compound for
mechanistic studies of chemical carcinogenesis. 2-AAF
is a potent carcinogen in at least eight different species
(2). The rat is the species most susceptible to the car-
cinogenic effect of 2-AAF and shows a marked sex-
related difference. The incidence of liver tumors is
higher in males, whereas females develop mammary
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tumors (3). In contrast to 2-AAF, the isomer 4-acety-
laminofluorene (4-AAF) isregarded as anoncarcinogen,
or at least a significantly less potent carcinogen than 2-
AAF (4). 4-AAF is a weak mutagen in the Ames test.
In addition to the two fluorene derivatives, we have
used 2-acetylaminophenanthrene (AAP) and trans-4-
acetylaminostilbene (AAS) as model compounds. AAP
produces no tumors in the liver, but is a potent mam-
mary carcinogen in the female rat and induces tumors
in other organs in both males and females (5). A typical
target tissue for the carcinogenic effect of AAS is the
Zymbal's gland (6). Forrat liver, AAS is not a complete
carcinogen, but has strong tumor-initiating properties.
The extent of DNA binding simply could not explain
the different carcinogenic activity of 2-AAF and AAS,
and it was proposed that these chemicals may differ in
their promoting properties (7). 2-AAF is a well-known
inducer of drug-metabolizing enzymes; the other aro-
matic amines have not been studied thoroughly in this
respect. 2-AAF is a tumor promoter in rat liver. The
mechanism of tumor promotion in general is not well
understood and it seems unlikely that only one mech-
anism is responsible. For a number ofdiverse chemical
tumor promoters, it is hypothesized that cellular recep-
tors may be involved. The strong tumor-promoting ef-
fect of the environmental contaminant 2,3,7,8-tetra-CIKRYT, KAISER, AND GOTTLICHER
chlorodibenzo-p-dioxin (TCDD) seems to be mediated
by the aromatic hydrocarbon (Ah) receptor (8). Plasma
membrane receptors may play a role in the promoting
effect of phorbol esters (9). In the case of synthetic
steroid hormones, it has been suggested that the es-
trogen receptor participates in the process of tumor
promotion (10).
The objective ofthe present study was to determine
the interaction of structurally related aromatic amines
with cellular receptors and to correlate these effects
with the tumor-promoting properties of aromatic
amines.
Methods
Analysis of Cytosolic Receptors, Animals,
and Treatment
The binding ofthe aromatic amines to the rat hepatic
cytosolic Ah receptor was measured by determining
their capacity to compete with 3H-TCDD as a ligand.
Rat hepatic cytosol, with a protein concentration of 7
mg/mL, was incubated with 3 nM 3H-TCDD and vary-
ing amounts ofthe aromatic amines, ranging from a 5-
to a 50,000-fold excess, at 4°C for2 hr. The Ah receptor
was analyzed using sucrose densitygradient (SDG) cen-
trifugation according to Tsui and Okey (11). Control
incubations were performed with a 500-fold excess of
2,3,7,8-tetrachlorodibenzofuran (TCDF) instead of un-
labeled TCDD because ofits greater solubility in water
and its similar affinity for the Ah receptor.
For the analysis of the estrogen receptor (ER), cy-
tosol was prepared in the presence of 20 mM sodium
molybdate (8S ER) or in the presence of400 mM NaCl
(4S ER). Cytosol was incubated with 10 nM 3H-17-13-
estradiol (E2) for 18 hr at 4°C. The nonspecific binding
was determined by the addition of 10 puM unlabeled
diethylstilbestrol (DES) to the complete mixture. Pro-
tein-bound radioactivity was analyzed by means ofSDG
centrifugation in a vertical tube rotor at 65,000 rpm for
150 min (8S ER) and for 165 min (4S ER) at 2°C using
gradients from 10 to 30% sucrose (8S ER) containing
20 mM sodium molybdate or from 5 to 25% sucrose (4S
ER) containing 400 mM NaCl. High performance gel
filtration was carried out on Superose 12 (Pharmacia,
Uppsala, Sweden). Proteins wereelutedwithaflowrate
of0.2 mL/min at 4°C with 20 mM sodium molybdate (8S
ER) or 400 mM NaCl (4S ER) in the buffer.
For the in vivo studies, female Wistar rats (180-
220g) were injected IP once daily for 5 days with 2-
AAF (100 ,umole/kg), AAS (20 ,imole/kg), or AAP (100
,umole/kg).
Results and Discussion
Affinity ofAromatic Amines to the Ah
Receptor
Competition experiments with aromatic amines with
the Ah receptor have demonstrated that binding ofthe
ligand 3H-TCDD is decreased by the aromatic amines
Table 1. Binding of aromatic amines and TCDF to the rat
hepatic cytosolic Ah receptor in vitro.
Compound IC50, M Ki, M
2-AAF 5.0 x 10-6 2.3 x 10-6
4-AAF > 100.0 x 10-6 NAa
2-AAP 6.0 x 10-6 2.7 x 10-6
AAS > 100.0 x 10-6 NA
TCDF 1.8 x 10-8 7.1 x 10-9
aNA, no affinity.
2-AAF and AAP in a concentration-dependent manner
(12). In contrast, the 2-AAF isomer, 4-AAF, and AAS
do not bind to the Ah receptor. The 50% inhibition con-
centrations (IC50) and the apparent inhibitor constants
(Ki) of the aromatic amines are given in Table 1. For
comparison, the IC50 value and the Ki value of TCDF
was determined with the same experimental protocol;
Ki values were calculated as previously described (13).
Thebindingconstants ofthe aromatic amines are nearly
three orders of magnitude higher than that of TCDF.
This raises the question of the specificity of the assay
in the presence ofhigh competitor concentrations. The
solubility of TCDD in aqueous solution is a matter of
controversy (14). We have routinely checked the con-
centration ofTCDD afterthe incubation period by mea-
surement ofradioactivity. The solubility ofthe radioli-
gand remained unchanged in the presence of the high
competitorconcentrations. Thepurityofthecompounds
was greater than 99%, and a contamination with a po-
tent Ah receptor ligand is unlikely.
The significance of the binding studies in vitro was
examined in vivo. Rats were treated with the aromatic
amines and monooxygenase activities were measured.
2-AAF and AAP increased ethoxyresorufin-O-deethy-
lase (EROD) and aromatic hydrocarbon hydroxylase
(AHH). Induction ofEROD activityis highlycorrelated
with the induction of P450IA1 (15,16). In addition, mi-
crosomal proteins were separated on SDS polyacrylam-
ide gel electrophoresis, and a Western blot with isoen-
zyme-specific antibodies was performed. Treating rats
with 2-AAF and AAP led to the induction of P450IA1
as well as of P450IA2 (unpublished data). Microsomes
ofrats treated with 3-methylcholanthrene (MC) (20 mg/
kg) were used as a control. MC induces both P450IA1
and P450IA2, but preferentially P450IA1. The amines
2-AAF and AAP are much less effective than MC as
inducers. The relative proportion of the P-450 isoen-
zymes induced is reversed by 2-AAF and AAP com-
paredtoMC, theamountofP450IA2proteinbeingmore
enhanced. Comparing the two amines, AAP is a more
potent inducer than 2-AAF in female rats at the same
dose. This was shown on the basis ofenzyme activities
as well as qualitatively byimmunoblotting. Microsomes
ofuntreated rats did not contain any detectable amount
of P450IA1 or P450IA2.
Induction of Ornithine Decarboxylase
Activity by Aromatic Amines in Rat Liver
The induction of ornithine decarboxylase (ODC)
214BINDING OF AROMATIC AMINES TO CELLULAR RECEPTORS
Table 2. Induction of ODC activity by aromatic amines in rat
liver.
Mean of ODC Peak time of Confidence
activity, ODC activity, level by
Compound mU/mg proteina hr Wilcoxon test
Control 36
MC 128 12 0.025
2-AAF 142 2.5 0.025
4-AAF 135 4 0.025
AAP 186 2.5 0.025
AAS 205 9 0.01
an = 4, control; n = 8, 2-AAF; n = 5.
seems to be associated with theAh gene locus in mouse
liver (17). In rat liver, however, a comparable associ-
ation has so far not been established (18). In the. mouse
skin tumor model, the induction of ODC was proposed
as a marker of tumor-promoting activity. In order to
correlate the Ah receptor affinity with the ODC induc-
ing capacity, we have measured the induction of ODC
activity in rats by treatment with various aromatic
amines (19). MC was used as a reference compound.
The results are given in Table 2. All aromatic amines
tested induce ODC activity in vivo irrespective oftheir
Ah receptor affinity. It is concluded that the induction
of ODC in the Wistar rat is not (strictly) under the
control of the Ah receptor.
Binding Studies of Aromatic Amines to the
8S and 4S Estrogen Receptor of Rat
Uterus and Rat Liver
The analysis ofthe ER ofrat uterus and rat liver was
performed by means of HPLC gel filtration and SDG
centrifugation. In the presence ofmolybdate, the chro-
matography of3H-E2 binding proteins ofuterus cytosol
yielded, with both techniques, only one peak in the sep-
aration range of proteins: the 8S ER. In the presence
of high ionic strength, the chromatograms of uterus
cytosol showed two peaks. The first peak in the void
volume of the column or at the bottom of the sucrose
gradient contained protein aggregates ofhighmolecular
weight with E2 binding capacity. The second peak
eluted after serum albumin, and we assume that this
peak contains the 4S estrogen receptor. The chroma-
tograms ofthe 8S and 4S ER ofrat uterus obtained by
HPLC gel filtration are shown in Figure 1. With rat
hepatic cytosol, the elution pattern of the 4S ER is
unchanged. However, the analysis ofthe8S ER showed
an additional peak which coeluted with the 4S ER. In
contrast to the 4S ER, the binding of3H-E2 tothe latter
peak is not entirely suppressed by an excess of unla-
beled DES.
The competition experiments with aromatic amines
and 3H-E2 binding to the 8S and 4S ER of rat uterus
and rat liver were analyzed using SDG. The concentra-
tion of the amines in the assay ranged from 0.1 ,uM to
0.5 mM. Typical binding curves of H-E2 the 4S ER
of rat uterus as a function ofincreasing concentrations
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FIGURE 1. Analysis ofthe 8S and 4S estrogenreceptorofratuterus
usingHPLCgelfiltration. Bindingof3H-17-p-estradiol toratuter-
ine cytosolic proteins in the presence of20 mM sodium molybdate
(A) (8S ER), and in the presence ofa 10,000-fold excess ofdieth-
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FIGURE 2. Competition experiments with aromatic amines and the
rat uterine 4S estrogen receptor. Binding of3H-17-p-estradiol to
the rat uterine 4S estrogen receptor in the presence ofincreasing
concentrations of 2-acetylaminofluorene (A), 2-acetylaminophen-
anthrene (U), and trans-4-acetylaminostilbene (0). Diethylstil-
bestrol(EO) was used as acontrol. The same results were obtained
with the nonacetylated amines.
curves reveal that aromatic amines do not bind to the
4S ER ofrat uterus. This also holds true for the 8S ER
ofratuterus and ratliver. Thecompetition experiments
of aromatic amines with the 4S ER of rat liver dem-
onstrate adisplacement ofthe ligand in aconcentration-
dependent manner (data not shown). However, com-
paring the 4S ER analysis of rat uterus and rat liver,
it is obvious that DES is less effective as a competitor
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in the case of the hepatic receptor. We assume that
another estrogen-binding protein of rat liver coelutes
with the 4S ER and that DES has no or only a low
affinity to this protein. The binding studies with the 4S
ER ofrat uterus clearly show no displacement ofE2 by
aromatic amines. Therefore, we conclude that the ar-
omatic amines bind to the coeluting estrogen-binding
protein.
The competition experiments in vitro did not show a
direct interaction of the aromatic amines with the ste-
roid bindingdomainoftheestrogenreceptor. However,
we cannot exclude the possibility that aromatic amines
modulate the estrogen receptor concentration in vivo
or that aromatic amines affect the binding ofthe estro-
genreceptorto DNA. In summary, we have shownthat
structurally related aromatic amines do interact differ-
entially with a specific cellular target protein: the cy-
tosolic Ah receptor.
Specific binding to key cellular receptors determines
at least in part the biological activity of numerous xe-
nobiotics. Onthe otherhand, the development ofcancer
asamultistep process involves aseriesofcellularevents
that are not yet fully understood even in the case of
tumor initiation. Because of the multiple factors, a di-
rect correlation between the carcinogenic activity of a
compound and a single cellular event is not to be ex-
pected. In the case of the Ah receptor, it has been
suggested that the receptor is involved in the growth
control of the cell and-participates in the process of
tumor promotion (8). However, the experimental basis
for this hypothesis is frail. The role ofthe Ah receptor
in the induction of drug-metabolizing enzymes is well
known, especially in the case of P450IA1 (20). It has
been noted that the induction ofdrug-metabolizing en-
zymes by many enzyme inducers leads to an increase
in their own metabolism. 2-AAF is an example of this
type ofinducer. From this point ofview, binding to the
Ah receptor in vivo should be related to the process of
tumor initiation rather than promotion if more or less
reactive intermediates were produced as a result ofthe
induction process. On the otherhand, enzyme induction
is a common property of many tumor promoters. The
correlation between Ah receptor affinity and the pro-
moting activity of the model compounds in rat liver,
however, is also not perfect. 2-AAF is a complete car-
cinogen for rat liver, and promoting properties have
been deduced from many experiments. AAP has been
less thoroughly studied, and promoting activity in liver
has not yet been demonstrated but cannot be excluded
because high doses have not been tested.
We are now focusing our interests on receptors that
are involved in the cellular signal transduction and in
the growth control ofthe cell: the growth factor recep-
tors of the plasma membrane. Even if the aromatic
amines donotbindtothesereceptors, theycouldchange
receptor levels or their binding constants, thereby in-
terfering with signal transduction.
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